Objective: To investigate the effects of oral administration of all-trans retinoic acid (ATRA) on inhibition of intimal thickening after balloon angioplasty in the rabbit iliac artery atherosclerotic model.
Methods: Iliac atherosclerosis was induced in 24 rabbits, and balloon angioplasty was performed. At angioplasty, 24 rabbits were randomly divided into four groups (n = 6 per group): Group 1: controls not receiving oral ATRA administration; Group 2: receiving oral ATRA (0.6 mg.kg-1.d-1) administration beginning 1 week prior to angioplasty and continuing for 4 weeks; Group 3: receiving oral ATRA (0.6 mg.kg-1.d-1) administration beginning immediately after angioplasty and continuing for 4 wk; Group 4: receiving oral ATRA (0.6 mg.kg-1.d-1) administration beginning 1 wk after angioplasty and continuing for 4 wk. Values of cross-sectional area, ratio of intimal/medial area and thickness were determined by a computer-based morphometric system, and cell proliferative activity was assessed by 3H-thymidine incorporation.
Results: Both the cross-sectional area and the ratio of intimal/medial area and thickness were significantly reduced by ATRA administration compared with control group (P < 0.01). The inhibitory effect is less potent when ATRA is administered 1 week before angioplasty. The ATRA inhibitory effect when administered 1 week after angioplasty is not different significantly form that when administered immediately after angioplasty. The 3H-thymidine incorporation was also decreased in ATRA-treated rabbits compared with controls (P < 0.01).
Conclusions: Oral ATRA administration can be effective in inhibiting intimal thickening after balloon angioplasty. It is reasonable that ATRA should be administered immediately after angioplasty.